Goldman Sachs Group (GS)
489.80
-27.07 (-5.24%)
NYSE · Last Trade: Apr 10th, 10:56 PM EDT
Detailed Quote
Previous Close | 516.87 |
---|---|
Open | 503.10 |
Bid | 481.34 |
Ask | 489.80 |
Day's Range | 474.00 - 503.10 |
52 Week Range | 387.12 - 672.19 |
Volume | 5,374,994 |
Market Cap | 168.22B |
PE Ratio (TTM) | 12.09 |
EPS (TTM) | 40.5 |
Dividend & Yield | 12.00 (2.45%) |
1 Month Average Volume | 3,503,027 |
Chart
About Goldman Sachs Group (GS)
Goldman Sachs Group is a leading global investment banking, securities, and investment management firm that provides a wide range of financial services to a diverse client base, including corporations, financial institutions, governments, and individuals. The company engages in various activities, including financial advisory services, underwriting of capital market transactions, asset management, and market making in securities and commodities. It is known for its expertise in mergers and acquisitions, risk management, and investment strategy, leveraging its extensive research capabilities and global reach to deliver innovative solutions in an ever-evolving financial landscape. Read More
News & Press Releases
Goldman Sachs upgrades BorgWarner to Buy, citing strong China exposure, hybrid growth potential, and limited tariff risk.
Via Benzinga · April 10, 2025
Shares of electric vehicle pioneer Tesla (NASDAQ:TSLA) fell 10.7% in the afternoon session after Wall Street sentiment toward the company turned more bearish, with several analysts cutting their forecasts and price targets. UBS analyst Joseph Spak issued the most bearish outlook, slashing his price target to $19, implying a potential 30% downside. Spak warned that while lower 2025 earnings expectations were becoming consensus, the broader earnings trajectory for Tesla still appeared overly optimistic and remained vulnerable to further downward revisions after Q1 2025 earnings are released.
Similarly, Goldman Sachs lowered its price target from $275 to $260, reflecting growing near-term risks. The firm pointed to weakening auto demand, softer consumer sentiment, rising tariff-related costs, particularly within Tesla's Energy division, and increasing uncertainty around U.S. EV policy. Despite these headwinds, Goldman highlighted that the long-term potential from Tesla's AI-driven initiatives could serve as a meaningful offset, providing an avenue for future growth beyond its traditional automotive business.
Separately, stocks gave back some of the gains from the previous day as the White House clarified the tariffs on imports from China would add up to 145%, while the baseline 10% tariffs remained in place for all countries. This reminded investors that the global trade environment remained volatile, limiting the potential for sustained market gains.
Also President Trump said he was willing to accept pain in the short term, and was aware his policies could cause a recession, but he remained more mindful of a more severe case of economic depression (higher unemployment and prolonged downturn).
For investors, this suggested that the administration could prioritize long-term structural shifts over near-term economic stability, further increasing policy-driven risk in the markets.
Via StockStory · April 10, 2025
Shares of automotive manufacturer Ford (NYSE:F)
fell 5.8% in the afternoon session after Goldman Sachs downgraded the stock, citing growing concerns over trade tariffs on imported vehicles and car parts, which are expected to pressure profit margins and disrupt supply chains across the industry. The firm added, "We downgrade Ford to Neutral from Buy to better reflect a more difficult cyclical dynamic including competition internationally, weaker consumer demand, and what we expect will be higher costs from tariffs.".
Via StockStory · April 10, 2025
The firm expects the net price of new vehicles in the U.S. to rise by about $2,000 to $4,000 over the next 6-12 months as car manufacturers pass on tariff-related costs, Reuters reported.
Via Stocktwits · April 10, 2025
According to an ongoing poll, 43% of the nearly 2,000 respondents believe that growth fears are “overblown.”
Via Stocktwits · April 10, 2025
Goldman Sachs slashes auto outlook, downgrades Ford, Lear & Visteon as tariffs and weak demand drag down Tesla, Rivian, and sector stocks.
Via Benzinga · April 10, 2025
The new trade policies, UBS said, are raising the cost of making a vehicle, subsequently raising the cost of a vehicle for consumers and negatively impacting demand.
Via Stocktwits · April 10, 2025
Trump's tariff hike on China will hammer GDP and jeopardize millions of jobs, Goldman Sachs warns.
Via Benzinga · April 10, 2025
Prada said that the transaction will be funded by €1.5 billion of new debt composed of €1.0 billion term loan and €0.5 billion bridge facility.
Via Stocktwits · April 10, 2025
UBS estimates that if left unmitigated, GM's annual cost headwind from tariffs could be $5B.
Via Stocktwits · April 10, 2025
On Wednesday, 2-year Treasury yields surged 18.8 basis points to 3.916% after briefly touching 4.01%, as safe-haven demand eased and investors pulled back bets on a Federal Reserve rate cut.
Via Stocktwits · April 10, 2025
Via The Motley Fool · April 9, 2025
Via Benzinga · April 9, 2025
Via The Motley Fool · April 9, 2025
The U.S. financial sector roared to life Wednesday afternoon, posting one of its strongest single-day gains in years. The sector skyrocketing following a surprise move by President Donald Trump announcing a 90-day suspension of tariffs.
Via Benzinga · April 9, 2025
Goldman Sachs upgraded Johnson & Johnson (JNJ) from Neutral to Buy, citing underappreciated Innovative Medicine business and upcoming product cycles.
Via Benzinga · April 9, 2025
Market awaits March inflation report, hoping for lower CPI to support rate cuts amid trade uncertainty. Goldman Sachs predicts in-line results.
Via Benzinga · April 9, 2025
WTI futures have tumbled more than 20% since President Trump’s ‘Liberation Day’ tariffs went into effect on April 2.
Via Stocktwits · April 9, 2025
U.S. District Judge Edgardo Ramos in Manhattan said the plaintiffs failed to show that Bristol Myers and Celgene Corp violated the federal Sherman antitrust law.
Via Stocktwits · April 9, 2025
Via The Motley Fool · April 9, 2025
Via The Motley Fool · April 9, 2025
Investors are baffled as U.S. Treasuries sink for the third consecutive day, and yields continue to rise across the curve, defying a long-standing market pattern during periods of stress. This is fueling speculations and concerns as the one safe haven during times of crisis now seems to be losing its luster.
Via Benzinga · April 9, 2025